Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Jaffee

Showing results (161-170 of 291) with videos related to

Pageof 30
Sort By:
Cancer Immunology Research|October 21, 2018
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCsBrian J Christmas, Christine I Rafie, Alexander C Hopkins, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially control regulatory T cell phenotype and function via CXCL9 and CCL22Saumya Y Maru, Meredith Wetzel, Jacob T Mitchell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2026
Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and functionSaumya Y Maru, Meredith Wetzel, Jacob T Mitchell, et al.
Cancer Research|July 25, 2019
Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing DataEmily F Davis-Marcisak, Thomas D Sherman, Pranay Orugunta, et al.
Gastroenterology|March 11, 2014
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of miceBridget P Keenan, Yvonne Saenger, Michel I Kafrouni, et al.
Oncotarget|April 29, 2017
Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancerMark Yarchoan, Melinda C Myzak, Burles A Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2019
Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic CancerAlex B Blair, Victoria M Kim, Stephen T Muth, et al.
Cell Reports Methods|September 30, 2023
Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analysesSahana Jayaraman, Janelle M Montagne, Thomas R Nirschl, et al.
JCI Insight|October 19, 2018
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancerHeather L Kinkead, Alexander Hopkins, Eric Lutz, et al.
Science Signaling|August 6, 2015
Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancerKelly Foley, Agnieszka A Rucki, Qian Xiao, et al.
Pageof 30

Showing results (161-170 of 291) with videos related to

Sort By:
Pageof 30
Cancer Immunology Research|October 21, 2018
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCsBrian J Christmas, Christine I Rafie, Alexander C Hopkins, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially control regulatory T cell phenotype and function via CXCL9 and CCL22Saumya Y Maru, Meredith Wetzel, Jacob T Mitchell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2026
Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and functionSaumya Y Maru, Meredith Wetzel, Jacob T Mitchell, et al.
Cancer Research|July 25, 2019
Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing DataEmily F Davis-Marcisak, Thomas D Sherman, Pranay Orugunta, et al.
Gastroenterology|March 11, 2014
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of miceBridget P Keenan, Yvonne Saenger, Michel I Kafrouni, et al.
Oncotarget|April 29, 2017
Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancerMark Yarchoan, Melinda C Myzak, Burles A Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2019
Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic CancerAlex B Blair, Victoria M Kim, Stephen T Muth, et al.
Cell Reports Methods|September 30, 2023
Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analysesSahana Jayaraman, Janelle M Montagne, Thomas R Nirschl, et al.
JCI Insight|October 19, 2018
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancerHeather L Kinkead, Alexander Hopkins, Eric Lutz, et al.
Science Signaling|August 6, 2015
Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancerKelly Foley, Agnieszka A Rucki, Qian Xiao, et al.
Pageof 30